Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1994-09-13
1996-12-10
Mosher, Mary E.
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
4353201, 4352402, C12N 701, C12N 510, C12N 1586
Patent
active
055830285
ABSTRACT:
Disclosed and claimed are DNA constructs encoding HSV glycoproteins. The constructs are recombinant vaccinia virus, and host cells infected by the recombinant vaccinia virus are also disclosed and claimed.
REFERENCES:
patent: 4088748 (1978-05-01), McAleer et al.
patent: 4113712 (1978-09-01), Funakoshi
patent: 4129646 (1978-12-01), McAleer et al.
patent: 4138287 (1979-02-01), Andersson et al.
patent: 4162192 (1979-07-01), Mizuno et al.
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4322499 (1982-03-01), Baxter et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4710463 (1987-12-01), Murray et al.
patent: 4722848 (1988-10-01), Paoletti et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 5110587 (1992-05-01), Paoletti et al.
patent: 5244792 (1993-09-01), Burke et al.
patent: 5338683 (1994-08-01), Paoletti et al.
Watson et al Science vol. 218 pp. 381-384 (1982).
Mackett et al Proc Natl Acad Sci USA vol. 79 pp. 7415-7419 (1982).
DeLuca, N. et al. 1982. Virology, vol. 122, pp. 422-423.
Pellett, P. E. et al. 1985. Journal of Virology, vol. 53, pp. 243-253.
Bzik, D. J. et al. 1984. Virology, vol. 133, pp. 301-314.
Pereira, L. et al. 1982. Journal of Virology, vol. 44, pp. 88-97.
Baxyby, Progr. Med. Virol. 19 (1975) 215-246.
Bolivar et al., Gene 2, 95-113 (1977).
Bossart et al., Chem. Abstr. 89 (1978) 56,251 n.
Campione-Piccardo et al., J. Virol. 31, 281-287 (1979).
Chem. Abstracts, 10th Coll. Index, (1977-1981), vols. 86-95, Virus, Animal, Vaccinia Virus.
Colbere-Garapin, Prod. Natl. Acad. Sci. USA 76, 3755-3759 (1979).
Comparative Diagnosis of Viral Diseases, vol. III, ch. 6, p. 277, Academic Press, New York, 1981.
Comprehensive Virology, Fraenkel-Conrad et al., vol. 3, ch. 5, pp. 405, 427, Plenum Press, New York.
Downie et al., Ann. Rev. Microbiol. 10 (1959) 237-252.
Ensinger et al., "Marker Rescue etc.", J. Virol. 48(2); 1983, 419-428.
Fenner, Virology 8 (1959) 499-507.
Fenner, Virology 5 (1958) 502-529.
Graham et al., Virology 52, 456-467 (1973).
Hamer et al., Nature 281, 35-40 (1979).
Joklik, Bacteriological Reviews 30 (1966) 33-66.
Jones et al., "Mapping of the Vaccinia Virus etc.", J. Virol. 49(1); 1984, 72-77.
Katz et al., C.A. 89 #39241s, (1978) of J. Antimicrob. Chemother. 1978 4(2): 159-162, Genetic Recombination Between Temperature Sensitive Mutuant and IBT Resistant Mutant of Vaccinia Virus.
Kruczek-Juszczyk C.A. 92#126795f, (1980) of Ann. Univ. Mariae Curie Sect. C, 1978, 33: 1-8, Interferon Introduction by Viral Nucleic Acids in Chick Embryo Fibroblasts.
Mackett et al., J. Gen. Virol. 45 (1979) 683-701.
Miller et al., J. Gen. Virol. 38 (1977) 135-147.
Mocarski et al.: Cell 22, 243 (1980).
Morse et al.: J. Virol. 26, 389 (1978).
Moss et al-J. of Virology, vol. 40, No. 2, Nov. 1981, pp. 387-389, & 393-395.
Moss et al-Chem. Abst. vol. 95 (1981) p. 217, 559k.
Nakano et al., "Molecular Genetics of Vaccinia etc.", Proc. Nat'l. Acad. Sci. USA 79, 1982, 1593-1596.
Nippon Zoki Pharm. C.A. 94 #7711g, (1981) of Jpn. Kokai Tokkyo Koho 8087724, 2 Jul. 1980, Selective Immune Enhancer.
Panicali et al., J. Virol. 37, 1000-1010 (1981).
Panicali et al., "Construction of Live Vaccines etc.", Proc. Nat'l. Acad. Sci. USA 80, 1983, 5364-5368.
Panicali et al., "Construction of Live Vaccines etc.", Proc. Nat'l Acad. Sci. USA 79, 1982, 4927-4931.
Panicali et al., C.A. 94 #135967g, 1981 of J. Virol., 1981, 37(3): 1000-10, Two Major DNA Variants Present in Serially Propagated Stocks of the WR Strain of Vaccinia Virus.
Paoletti et al., Jan. 1984, PNAS 81:193-197.
Post et al., Cell 25 (1981) 227-2333.
Sam et al., Ann. Virol. 132 E. 135-150 (1981).
Sarver et al., Ann. Virol. 132 E. 135-150 (1981).
Schuemperli et al.-Chem. Abst. vol. 92 (1980) p. 124, 733k.
Shigeru et al., C.A. 86., #3119g, 1977 of Yakugaku Zasshi (1976)96(10): 1247-1254, Protein Inhibitors of Gastric Acid Secretion Isolated From Vaccinia Virus-Infected Tissues.
Shigeru, C.A. 88., #55061t, 1978 of Japan Kokai 77116402, 29 Sep. 1977, Gastric Juice Secretion-Inhibiting Protein From Vaccinia Virus Infected Animal Tissues.
Shimotohno et al., Cell 26, 66-77 (1981).
Smiley, Nature 285 (1980) 333-335.
Smith. G. L. et al., Dec. 1983 PNAS 80:7155-59.
Smith. G. C. et al., 7 Apr. 1983, Nature 302; 490-495.
Sveda et al., Proc. Natl. Acad. Sci. USA 78, 5488-5492 (1981).
Third Povirus-Iridovirus Workshop, Sep. 15-18, 1980, Workshop Program.
Villarreal et al., Science 196, 183-185 (1977).
Virology, Dulbecco et al., Ch. 56, pp. 1079 and 1082-1085, Harper & Row, Hagerstown.
Weir et al., "Mapping of the Vaccinia Virus etc.", Proc. Nat'l. Acad. Sci. USA 79, 1982, 1210-1214.
Wigler et al., Cell 11, 223-232 (1977).
Wigler et al., Proc. Natl. Acad. Sci. USA 76, 1373-1376 (1979).
Williams, N., 1 Dec. 1983, Nature 306:427.
Wittek et al., J. Virol. 23 (1977) 669-678.
Woodroofe et al., Virology 16 (1962) 334-341.
Woodroofe et al., Virology 12 (1960) 272-282.
Badgy et al., "Methods in Enzymology", vol. 45., 669-678 (1976).
Itakura et al., Science, 1056-1060 (1974).
Bonnerjea et al., vol. 4, 954-958 (1986).
Sofer et al., vol. 1, 198-203 (1983).
Bossart, et. al., Chem Abstr. 89, (1978) 56,251n.
Chem. Abstracts, 10th Coll. Index, (1977-1981), vols. 86-95, Virus, Animal Vaccinia Virus.
Comprehensive Virology, Fraenkel-Conrad et. al., vol. 3, Ch. 5, pp. 405, 427, Plenum Press, New York.
Ensinger, et. al., "Marker Rescue . . . " J. Virol. 48(2); 1983, 419-428.
Fenner, F., Virology, 8, 499-507, (1959).
Abstracts from Pox-Iridovirus Meeting, Cold Spring Harbor, Sep. 20-23, 1982, J. Holowczak, Rutgers Medical School, Riccardo Wittek, University of Lausanne, Participant Housing List.
Nakano, et al., Abstract from Third Poxvirus-Iridovirus Workshop, Cold Spring Harbor, Sep. 15-18, 1980, Workshop Program.
Declaration of Marion Perkus, Nov. 10, 1993, In re: European Pat. No. 0 110 385 B1, European Appln. No. 83 111976.3.
Panicali Dennis
Paoletti Enzo
Health Research Incorporated
Mosher Mary E.
LandOfFree
Recombinant vaccinia virus as DNA constructs encoding HSV glycop does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant vaccinia virus as DNA constructs encoding HSV glycop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccinia virus as DNA constructs encoding HSV glycop will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423574